Posts in Colombia
IOPtima Selects bioaccess.™ as Market Access Consultant to Find Distributors in Latin America

IOPtima Ltd.—an innovative ophthalmology medical device company based in Israel— has selected bioaccess.™ as its market access and business development consultant to expand its market reach to Latin America. bioaccess.™ will assist IOPtima with searching and selecting distributors in Colombia, Chile, Mexico, and Peru. 

Read More
London-based WEP Clinical Selects bioaccess.™ As Market Access Consultant to Enter the Colombian Market and Provide Patients Access to Life-Savings Drugs

WEP Clinical —a London-based drug sourcing, and distribution company— has selected bioaccess.™ as its market access, regulatory and business development consultant to enter the Colombian market for hard-to-find drugs. For hospitals or health management organizations (HMOs) that want to provide a life-saving and hard-to-find drug to their patients, WEP Clinical offers an efficient, end-to-end product distribution model. From the required regulatory filings, through to product handling and delivery, WEP Clinical is well positioned to support patient's needs.

Read More
MMT Appoints bioaccess.™ as Market Access and Regulatory Consultants in Colombia for its AcquiCell® Medical Device

Millenlum Medical Technologies, Inc. ("MMT"), a company specializing in manufacturing and distributing medical devices in liposuction, body shaping, adipose tissue collection and transfer, and autologous cell processing, has selected bioaccess.™ as its market access, regulatory consultant and legal representative in Colombia. bioaccess.™ will help MMT conduct market research, build a distribution network, and obtain marketing authorization for its novel AcquiCell® equipment at Colombia's medical device regulatory agency, INVIMA. 

Read More
SANUWAVE Appoints BIOACCESS™ as Territory Sales Manager and Partner to Access Clinical Trial Participation in Colombia; Revenue Expected Before Year End.

SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company has appointed Interventional Concepts, Inc. to act as Territory Sales Manager for sourcing and screening of potential distributors and access to clinical trials participation for SANUWAVE's products in Colombia.

Read More
Life-saving artificial pancreas startup considers Colombia for its first-in-human trial

An Asheville doctor-and-son team have an idea they say could save at least 100,000 lives a year. Leon and Jeremy DeJournett have patented an artificial pancreas, a system that uses a form of artificial intelligence to ensure patients’ glucose levels don’t get too high or low. Their company is called Ideal Medical Technologies and is considering conducting its first-in-human trial in Colombia. 

Read More
Interventional Concepts and Immunotrex partner for a Phase 0 study to be conducted in Colombia on a novel anti-sepsis compound

Immunotrex Biologics —a Boston-based biotech startup company developing a novel anti-sepsis compound capable of blocking the multiple pathophysiologic processes involved in sepsis— has selected Interventional Concepts —a leading US-based contract research organization for innovative life science startup companies— to design a Phase 0 human study to understand the effects of the compound in the human system and how the human body processes it. Immunotrex intends to conduct this study at a clinical research center in Colombia. Interventional Concepts, through an strategic alliance with JSS Research, will design the study, will select the center and principal investigator in Colombia, and will facilitate the regulatory approval process, among other activities necessary to make the study a success in Colombia.

Read More
Colombia becomes the most clinical trial-friendly country in Latin America; it now boasts the best study protocol approval times in the region: 30 days for medical devices and 60 days for drugs

Colombia's National Institute of Food and Drug Monitoring (INVIMA), announced that it has reduced from 4.5 months (135 days) to 2 months (60 days) the processing time for the evaluation and approval of a clinical research human study protocol involving an investigational drug. INVIMA announced this change on its website on April 12, 2016, and also stated that it would achieve this time reduction by improving the efficiency of internal processes without compromising the quality of the evaluation of the study protocol.

Read More
Colombia's Keraderm and Interventional Concepts join forces for a first-in-human trial to validate a technology to remodel and reconstruct skin tissue

Keraderm, an innovative product to heal skin defects based on cultures of keratinocytes and fibroblasts, developed in Colombia by Dr. Rodrigo Soto, Jennifer Gaona and Juan Zambrano, has joined forces with Interventional Concepts to design and manage a clinical study in humans. The study results will allow the product to be approved for commercialization by Colombia's Invima and other international regulatory bodies as a requirement for global expansion.

Read More
Colombian leading ophthalmologist and Interventional Concepts joined forces to develop an innovative medical device for cataract surgeries

Clínica Oftalmológica del Caribe (COFCA), located in Barranquilla, Colombia, has received funding from Colombia's Administrative Department of Science, Technology and Innovation (COLCIENCIAS) to develop an injection system of viscoelastic substances during cataract surgery invented and patented by Dr. Luis Escaf, its founder and medical director. Ophthalmology experts agree that the quality and number of corneal endothelial cells decrease after intraocular surgery, especially during cataract phacoemulsification. The good health of the eye's endothelium ensures that the cornea is transparent and healthy. If the cornea is not transparent after cataract surgery, the patient's vision is impaired, so specialists need to perform a corneal transplant or transplant corneal endothelium to the damaged eye. Dr. Luis Escaf's device prevents the damage to the eye during cataract surgery. The prototype is being developed by Interventional Concepts' bioengineering team in Miami, FL. The project will be led by Dr. Pedro Martinez-Clark, a Colombian-born physician with extensive medical device development track record in the US. 

Read More
Dr. Pedro Martinez-Clark presented our proposed Colombia Life Sciences Initiative to the Colombian Ambassador to the United States —Colombia will be Latin America's life sciences innovation star

Colombia's vision by 2025 is to become one of the top three innovative countries in Latin America by promoting human capital for the knowledge economy, research and development (R&D) and innovation; and by raising awareness of science, technology and innovation in the Colombian society. The initiative seeks to attract foreign innovative life sciences startups to Colombia by offering them R&D funding and a generous 175% capital allocation tax deduction —among other incentives. 

Read More
Annual ranking reveals that Colombia has the best hospitals and clinics in Latin America

Talent, innovation and service explain why Colombia leads the annual ranking of the best clinics and hospitals in Latin America. According to America Economía magazine's annual ranking of clinics and hospitals in Latin America, Colombia leads the region with 22 of the best institutions out of 43 in the list. Medellin's General Hospital leads the ranking as the best public health institution in Latin America. 

Read More